Axios Pro: Health Tech Deals

September 16, 2022

Axios Pro Exclusive Content

Happy Friday, Health Tech readers. You've got newsletter editor Claire Rychlewski, back with a digest of this week's news.

πŸŽ™ Axios’ acclaimed podcast "How it Happened" is back with "Elon Musk vs. Twitter" β€” a docu-series about Musk's astonishing career, the rise of Twitter, and what the collision between the two could mean for us all. Subscribe and listen.

1. Spectrum Science scoop

Illustration of a line of doors with hundred dollar overlays
Illustration: Sarah Grillo/Axios

Spectrum Science, a founder-led life sciences communications business, is exploring strategic alternatives in response to inbound interest, sources told Sarah Thursday.

Why it matters: Many scale assets in this space have come to market and transacted over the last 18 months. Spectrum, while smaller, is fast-growing β€” presenting an opportunity for PE groups that have gotten educated on med comms (and chased other assets) but have yet to score an entry point.

Read the full newsletter.

Plus: ⌨️ Thursday's Pro Rata, with news on Adobe's $20b Figma buy.

View archive